The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet
UnitedHealth’s repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.
Medicare Is Tracking Better, Commercial Is Not
For 2026, management expects the Medicare medical cost trend to land below its initial estimate of around 10%, and says the Medicaid trend is broadly in line. Commercial went the other way.
The Medicare and commercial trends are moving apart. Management credits its own benefit design, care management and network curation, plus a lighter respiratory season, for Medicare landing below plan.
On commercial it says the opposite: costs are running high and above what it expected, with no evidence yet of moderation. Its own explanation starts with a federal arbitration process that only commercial plans face.
A Few Firms Are Behind Most Of The Disputes
That process is the independent resolution process under the No Surprises Act. Management characterizes the process as ineffective, stating on its earnings call that IDR dispute awards contributed approximately 50 basis points of incremental medical cost trend in 2026 and now accounts for at least 100 basis points of total cost.
The shape of that cost is unusual. Roughly 60% of all arbitration cases are brought by one of just five entities, and the average payout when arbiters side with out-of-network providers is now 11 times what Medicare would pay. Management also points to heavier coding intensity at office visits and emergency departments. It describes the commercial margin repair as a multi-year journey.
The Commercial Margin Fix Has Slipped Past 2027
UnitedHealth (UNH) came into 2026 planning for commercial margin expansion, and says it is not getting the full expansion it planned. Management says the elevated trend is extending the timeframe for full commercial margin recovery past 2027. It calls 2026 a delay rather than a setback.
That date matters, because UnitedHealth’s operating margin over the last twelve months, at 4.8%, is still below its three-year average of 7.1%. Its second quarter ran closer to that average, on $8 billion of operating earnings against $112 billion of revenue. The shares, meanwhile, have returned about 33% over the past six months. They recovered a long way ahead of those margins.
The Recovery Is Real, And Commercial Is Still Behind
Give the turnaround its due. Management lifted 2026 adjusted earnings per share guidance to $19.50 to $20, and says it still believes in its 13%-16% long-term growth rate. The commercial book running late does not undo that.
The worry is narrower, and it is about a date that has already moved once. Watch whether commercial cost trend moderates when third-quarter 2026 results are reported. Management says the arbitration process behind it needs to be reformed. Options are pricing a larger move than normal. Implied volatility sits at 33, in the 66th percentile of its trailing one-year range. The size of the move being priced is worth knowing before you act.
Could One Warning Sign Cost You Years Of Gains?
A warning in the fundamentals is manageable when you are diversified and dangerous when you are not. Concentration tends to arrive by accident rather than by decision. What your largest position would do to your net worth is exactly what the Trefis Wealth team computes, with the same rules-based systematic discipline that runs our High Quality Portfolio. Request a free vulnerability audit of your biggest positions.